Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04379284 · ClinicalTrials.gov registry record
Risks of COVID19 in the Pregnant Population
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 69
- Enrollment target
NCT04379284: Completed study, sponsored by Mayo Clinic.
NCT04379284 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 69 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04379284 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 69 participants
- Enrollment target
Study Summary
It is unclear how COVID19 can be passed from mother to infant. The study investigators aim to collect maternal and neonatal samples from COVID19-infected pregnant women and compare them to pregnant women who have clinical indications for COVID 19 testing at the time of hospital admission but end up being COVID19 negative. Pregnant women who are either COVID19 positive or COVID19 negative with respiratory symptoms will be enrolled and followed during this study.
Primary Outcome
Standardized testing of maternal, placental, and neonatal specimens will be used to determine presence of current infection with SARS-CoV2. Clinical RT-PCR assays will be used to determine the presence of viral RNA in all specimens.
Interventions
- OTHER Biospecimen collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2020-05-08 |
| Est. Completion | 2021-10-01 |
What the finished NCT04379284 record still lists
NCT04379284 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 69 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Biospecimen collection is the first listed.
NCT04379284 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04379284 about?
NCT04379284 is a clinical study titled "Risks of COVID19 in the Pregnant Population". It is unclear how COVID19 can be passed from mother to infant. The study investigators aim to collect maternal and neonatal samples from COVID19-infected pregnant women and compare them to pregnant women who have clinical indications for COVID 19 testing at the time of hospital admission but end up ...
What is the current status of trial NCT04379284?
This trial is currently completed. The enrollment target is 69 participants. The study started on 2020-05-08. Estimated completion is 2021-10-01.
What interventions are being tested in trial NCT04379284?
The interventions under investigation include: Biospecimen collection (OTHER).
Who is sponsoring clinical trial NCT04379284?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI